metastases

Related by string. Metastases * * lymph node metastases . distant metastases . brain metastases originating . nodal metastases . occult metastases . bony metastases . bone metastases . brain metastases . liver metastases . lung metastases . colorectal liver metastases . Bone metastases . skeletal metastases . Bone Metastases . Brain Metastases . pulmonary metastases . tumor metastases *

Related by context. Frequent words. (Click for all words.) 79 metastasis 76 metastatic disease 75 tumors 73 metastatic cancer 71 metastatic 71 lung tumors 71 carcinoma 70 carcinomas 69 malignancies 69 lesions 68 tumor 68 malignancy 67 adenomas 66 brain metastases 66 lymph nodes 66 pancreatic cancers 65 breast tumors 65 tumor cells 64 prostate cancers 64 lymph node 64 gastric cancer 64 malignant tumors 63 melanomas 63 hepatocellular carcinoma 63 breast cancers 63 bone metastases 63 cancers 62 resection 62 fibrosis 62 adjuvant therapy 61 renal cell carcinoma 61 recurrences 61 Tumors 61 NSCLC 61 lesion 61 squamous cell carcinoma 61 colorectal cancers 61 ovarian cancers 61 solid tumors 61 adenocarcinoma 60 polyps 60 HER2 positive 60 tumor shrinkage 59 nodules 59 malignant cells 59 medulloblastoma 59 follicular lymphoma 59 cancerous cells 59 pathologic 59 biopsies 59 cancerous tumors 59 lymphomas 58 tumor progression 58 breast cancer recurrence 58 testis 58 glioblastoma 58 lung cancers 58 disease progression 58 metastatic melanoma 57 colorectal cancer 57 cisplatin 57 dysplasia 57 radical prostatectomy 57 melanoma 57 colon cancers 57 autoantibodies 57 Barrett esophagus 56 EGFR 56 epithelial 56 chromosomal abnormalities 56 precancerous lesions 56 basal cell carcinoma 56 metastatic breast cancer 56 sarcoma 56 gliomas 56 benign tumors 56 overexpression 55 adjuvant chemotherapy 55 cysts 55 prostate tumors 55 NAFLD 55 chemotherapeutic agents 55 cetuximab 55 cancerous tissue 54 mutations 54 trastuzumab 54 oncogenes 54 HER2 54 zoledronic acid 54 rectal cancer 54 GIST 54 gefitinib 54 evaluable patients 54 vasculature 54 toxicities 54 bortezomib 53 advanced NSCLC 53 stenosis 53 phenotype 53 radiation therapy 53 localized prostate cancer

Back to home page